Krilogy Financial’s Sucampo Pharmaceuticals, Inc. SCMP Stock Holding History

Krilogy Financial’s Portfolio SCMP Stock Details SCMP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-300	Closed	-$5K	–	844
2017 Q4	$5K	Hold	300	–	–	﹤0.01%	617
2017 Q3	$4K	Buy	300 +100	+50%	+$1.12K	﹤0.01%	690
2017 Q2	$2K	Hold	200	–	–	﹤0.01%	681
2017 Q1	$3K	Hold	200	–	–	﹤0.01%	638
2016 Q4	$3K	Hold	200	–	–	﹤0.01%	638
2016 Q3	$2K	Hold	200	–	–	﹤0.01%	683
2016 Q2	$2K	Hold	200	–	–	﹤0.01%	699
2016 Q1	$2K	Buy	+200	New	+$2.53K	﹤0.01%	624
2015 Q4	–	Sell	-200	Closed	-$4K	–	633
2015 Q3	$4K	Buy	+200	New	+$4.58K	﹤0.01%	504

Other funds holding SCMP

Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

AIM

Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

Krilogy Financial's SCMP Position: Q1 2018 in Review

Krilogy Financial sold out of Sucampo Pharmaceuticals, Inc. (SCMP) in Q1 2018, closing a stake of 300 shares — an estimated $5K sold.

Krilogy Financial first reported a position in SCMP in Q3 2015 and held it in 9 quarters. The position peaked at $5K in Q4 2017. 3 funds tracked by Wall St. Rank hold SCMP as of Q1 2018.

Krilogy Financial reported no remaining Sucampo Pharmaceuticals, Inc. position as of Q1 2018 after selling out during the quarter.
Krilogy Financial sold 300 Sucampo Pharmaceuticals, Inc. shares in Q1 2018, an estimated $5K.
Krilogy Financial first reported a position in Sucampo Pharmaceuticals, Inc. in Q3 2015 and held it in 9 quarters.
Krilogy Financial's Sucampo Pharmaceuticals, Inc. position peaked at $5K in Q4 2017.
3 funds tracked by Wall St. Rank held Sucampo Pharmaceuticals, Inc. as of Q1 2018.

Based on Krilogy Financial's 13F filing for Q1 2018, filed 15 May 2018.